Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Vivus Needs Catalyst For Qsymia
Seeking Alpha
Wed, 12/4/13 - 08:15 am
Tags:
Vivus, Qsymia, obesity
[video] A Chart You Should See: Investors Put Greater Weight Behind Orexigen Than Arena, Vivus
TheStreet.com
Mon, 11/25/13 - 12:54 pm
Tags:
Orexigen, obesity, Contrave, Vivus, Arena Pharmaceuticals
Profit bonanza eludes companies chasing obesity business
Reuters
Fri, 11/15/13 - 09:42 am
Tags:
obesity, diabetes, Novo Nordisk, Arena Pharmaceuticals, Vivus
5 FDA-Approved Drugs That Disappointed Investors in 2013
Motley Fool
Wed, 11/13/13 - 10:33 pm
Tags:
FDA, Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Provenge, Vascepa, Iclusig, Ariad Pharmaceuticals, Belviq, Qsymia
Can Orexigen Therapeutics Catch Up With Arena Pharmaceuticals and VIVUS?
Motley Fool
Mon, 11/11/13 - 10:19 am
Tags:
Arena Pharmaceuticals, Vivus, obesity, Orexigen, Contrave, Belviq, Qsymia
This Week in Biotech
Motley Fool
Sun, 11/10/13 - 12:56 pm
Tags:
Keryx, Geron, Arena, Eisai, Vivus, Curis, Immunogen
Key Takeaways From Vivus' Bad Quarter
Motley Fool
Sat, 11/9/13 - 12:26 pm
Tags:
Vivus, earnings
The Good, Bad, and Ugly of VIVUS' Earnings
Motley Fool
Thu, 11/7/13 - 08:11 am
Tags:
Vivus, earnings
With Qsymia still flailing, Vivus to cut 20 jobs, replace CFO
Fierce Pharma
Wed, 11/6/13 - 03:37 pm
Tags:
Vivus, layoffs, Qsymia
When Japanese Pharma Report, These American Biotechs React
Motley Fool
Sat, 11/2/13 - 11:22 am
Tags:
Arena Pharmaceuticals, Medivation, JNJ, Vivus, Astellas, Eisai
Vivus Outlines Key Data Points
Seeking Alpha
Wed, 10/16/13 - 09:31 am
Tags:
Vivus, obesity, Qsymia
Vivus, Auxilium sign $300 mln deal for erectile dysfunction drug
Reuters
Fri, 10/11/13 - 08:57 am
Tags:
Vivus, erectile dysfunction, Auxilium, Stendra
Vivus says drug delayed progression to diabetes
Yahoo/AP
Wed, 10/9/13 - 10:39 pm
Tags:
Vivus, diabetes, Qsymia
[video]Can This Obesity-Drug Maker Beat Arena and VIVUS in Europe?
Motley Fool
Mon, 10/7/13 - 09:12 am
Tags:
obesity, Europe, Vivus, Arena Pharmaceuticals, Belviq, Qsymia, Contrave, Orexigen
Why VIVUS Is Poised to Bounce Back
Motley Fool
Sat, 10/5/13 - 09:26 am
Tags:
Vivus
What's Moving These 3 Biotechs?
Motley Fool
Fri, 10/4/13 - 12:16 pm
Tags:
Ligand, Pfizer, Vivus, Omeros
Obesity drug makers jockey for position as analysts praise Vivus
Marketwatch
Thu, 10/3/13 - 05:29 pm
Tags:
obesity, Vivus, Belviq, Arena Pharmaceuticals, Contrave, Orexigen, Qsymia
Things Just Got A Little Brighter For Vivus
Seeking Alpha
Thu, 10/3/13 - 11:58 am
Tags:
Vivus, Qsymia
Will Arena Be Able To Write A Growth Story?
Seeking Alpha
Mon, 09/30/13 - 04:51 pm
Tags:
Arena Pharmaceuticals, Vivus, Eisai
VIVUS' Hopes Tied to Qsymia
Yahoo/Zacks
Thu, 09/26/13 - 08:51 am
Tags:
Vivus, Qsymia, obesity

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.